Full history for every metric is available with a Kvantra account
McKesson Europe AG (CAKFY)
Key financial summary
Financials in EUR| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | €bn | 21 | 21 | 21 | 17 | 17 | 9 | 22 |
| Operating profit | €bn | 0 | 0 | |||||
| Net profit | €bn | -1 | -0 | -0 | -0 | 0 | -0 | 0 |
| EPS reported | € | -0.05 | 0.17 | |||||
| Operating cashflow per share | € | 0.00 | 0.00 | |||||
| Capex per share | € | 0.00 | 0.00 | |||||
| FCF per share | € | 0.00 | 0.00 | |||||
| Free cash flow | €bn | 0 | 0 | |||||
| Net debt | €bn | 0 | 0 | |||||
| Book value equity | €bn | 2 | 2 | |||||
| Book value per share | € | 2.45 | 1.82 | |||||
| Number of shares | m | 1,016.1 | 1,030.36 | |||||
| DPS (TTM paid) | € | 0.17 | 0.00 |
Financial summary
Financials in EUR| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 1.84 | 2.55 | |||||
| P/S LTM | x | 0.50 | 0.22 | |||||
| P/FCF LTM | x | 5,099.15 | 31.27 | |||||
| EV/EBITDA LTM | x | 21.80 | 8.33 | |||||
| EV/Sales LTM | x | 0.52 | 0.22 | |||||
| Earnings Yield LTM | % | -1.08% | -1.38% | |||||
| FCF Yield | % | 0.02% | 3.20% | |||||
| Quality | ||||||||
| ROE | % | -1.98% | -2.26% | |||||
| ROIC | % | 2.06% | 2.06% | |||||
| Operating margin | % | 0.64% | 0.64% | |||||
| Gross margin | % | 8.68% | 8.68% | |||||
| FCF/Sales | % | 0.01% | 0.01% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | +99.30% | |||||
| Sales Growth YoY | % | -44.73% | -0.31% | |||||
| Net Income Growth YoY | % | - | +114.32% | |||||
| FCF Growth | % | -99.66% | -8.35% | |||||
| Operating Profit Growth | % | -55.41% | +13.95% | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 3.74% | 0.00% | |||||
| Dividend Growth | % | +2.28% | - | |||||
| Payout Ratio | % | -347.67% | -347.67% | |||||
| FCF/Debt | x | 0.00 | 0.29 | |||||
| Net Debt/EBITDA | x | 0.82 | 0.82 | |||||
| EBIT/Net interest | x | 3.80 | 3.80 | |||||
| Net debt/market cap | % | 3.89% | 0.95% | |||||
| Net debt/Equity | x | 0.07 | 0.02 | |||||
| Gross debt/equity | x | 0.07 | 0.28 | |||||
Company overview
McKesson Europe AG is a global provider of logistics and a variety of services to the pharmaceutical and healthcare industries. Its operations are structured into two main segments: Pharmaceutical Distribution and Retail Pharmacy. The Pharmaceutical Distribution arm focuses on the wholesale supply of medicines and other health-related products. It reaches approximately 40,000 pharmacies and hospitals via 90 wholesale branches and manages 70 distribution centers across Europe. Meanwhile, the Retail Pharmacy division oversees roughly 2,000 company-owned pharmacies and collaborates with around 8,000 partners through its brand program. Under the Lloyds Pharmacy brand, this segment also delivers outpatient medication services, e-commerce solutions, and home care, principally in Belgium, Ireland, Italy, and the United Kingdom. Its offerings extend to traditional prescription drugs, over-the-counter (OTC) items, and various medical services. Furthermore, it supports pharmacists by organizing and managing pharmacy cooperation initiatives in Great Britain, France, Portugal, and Belgium. Established in 1835, the company's roots trace back to its former identity, Celesio AG, before rebranding as McKesson Europe AG in September 2017. Headquartered in Stuttgart, Germany, it operates as a subsidiary of McKesson Corporation.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
McKesson Europe AG (CAKFY)
McKesson Europe AG is a global provider of logistics and a variety of services to the pharmaceutical and healthcare industries. Its operations are structured into two main segments: Pharmaceutical Distribution and Retail Pharmacy. The Pharmaceutical Distribution arm focuses on the wholesale supply of medicines and other health-related products. It reaches approximately 40,000 pharmacies and hospitals via 90 wholesale branches and manages 70 distribution centers across Europe. Meanwhile, the Retail Pharmacy division oversees roughly 2,000 company-owned pharmacies and collaborates with around 8,000 partners through its brand program. Under the Lloyds Pharmacy brand, this segment also delivers outpatient medication services, e-commerce solutions, and home care, principally in Belgium, Ireland, Italy, and the United Kingdom. Its offerings extend to traditional prescription drugs, over-the-counter (OTC) items, and various medical services. Furthermore, it supports pharmacists by organizing and managing pharmacy cooperation initiatives in Great Britain, France, Portugal, and Belgium. Established in 1835, the company's roots trace back to its former identity, Celesio AG, before rebranding as McKesson Europe AG in September 2017. Headquartered in Stuttgart, Germany, it operates as a subsidiary of McKesson Corporation.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free